Sildenafil Tablet, Film Coated
Product Images NDC 51407-987

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 51407-987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-987-90lb (Sildenafil Tablets 20g)

The packaging label for Sildenafil Tablets, USP, 20 mg, film-coated oral tablets. The label shows the NDC number 51407-987-90 and indicates a package size of 90 tablets. It includes dosage information, storage instructions, and manufacturer info for Golden State Medical Supply, Inc. The label features a QR code, barcode, and prescription-only status.*

FDA Label Image

Fig-1 (Fig 1)

A chart displaying drug interaction effects on sildenafil pharmacokinetics. It shows fold changes and 90% confidence intervals for AUC and Cmax values when sildenafil is coadministered with various drugs like Atorvastatin, Azithromycin, Bosentan, and others. Recommendations regarding dose adjustments or coadministration are included, with most indicating no dose adjustment needed except for Bosentan and Ritonavir where coadministration is not recommended.*

FDA Label Image

Fig08 (Fig08)

A chart depicting fold change and 90% confidence intervals for various drugs interacting with sildenafil tablets 20 mg. The chart shows changes in pharmacokinetic parameters (INR, AUC, Cmax) relative to the interacting drug alone, along with dosing recommendations such as 'No dose adjustment' or cautions like 'Coadministration not recommended' for certain drugs.*

FDA Label Image

Fig09 (Fig09)

A line chart depicting change from baseline in meters over weeks of study (Week 4, Week 8, Week 12) for different doses of sildenafil (20 mg TID, 40 mg TID, 80 mg TID) and placebo. The x-axis represents time points and the y-axis shows change from baseline with error bars for variability. The legend identifies symbols for placebo and each sildenafil dose.*

FDA Label Image

Fig10 (Fig10)

Forest plot comparing placebo and Sildenafil 20 mg TID groups showing placebo-corrected change in 6-minute walk distance (m). Variables include baseline walk distance, etiology, PH criteria for functional capacity, gender, age, mean PAP, and PVRI, each with subgroup sample sizes and confidence intervals around mean changes.*

FDA Label Image

Fig11 (Fig11)

A line graph comparing the percentage of patients without a clinically worsening event over time between Sildenafil and placebo groups. The x-axis represents days from randomization (0 to 112), and the y-axis shows the percentage without worsening events (0 to 100%). Sildenafil shows a higher percentage without worsening events consistently over time compared to placebo.*

FDA Label Image

Structure (Structure)

Chemical structure of sildenafil, the active ingredient in the Sildenafil 20 mg film-coated tablet by Golden State Medical Supply, Inc. The diagram shows the molecular arrangement of atoms and bonds characteristic to sildenafil.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.